ArticleLancet (London, England)2014

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.

Lee-Jah Chang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.